Skip to content

DIEP Flap Surgery and Intraabdominal Pressure

Intraabdominal Pressure Increases Peri-operatively in Patients Undergoing DIEP Flap Reconstruction: A Prospective Study Linking High IAP to Non-fatal Lung Embolism in One Patient

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05764577
Enrollment
13
Registered
2023-03-10
Start date
2021-04-19
Completion date
2022-01-25
Last updated
2023-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Intraabdominal Hypertension

Brief summary

Aim: The primary aim of this study is to test if closure of the abdominal donor site increases the Intraabdominal Pressure (IAP) in women undergoing secondary Deep Inferior epigastric perforator (DIEP) flap breast reconstruction. Materials and method: By an Unometer, attached to a standard catheter in the bladder, we measured the intravesical pressure as a surrogate marker for the IAP, at baseline, immediate after- and 24 hours after abdominal skin closure, for 13 patients.

Interventions

PROCEDUREDIEP flap surgery

Removal off the DIEP flap followed by closure of the rectus sheath and abdominal skin.

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Females undergoing secondary DIEP flap breast reconstruction. * Performance status 1-2

Exclusion criteria

* Performance status above 2. * Untreated hypertension or atrial fibrillation Performance status evalutated using American Society of Anaesthesiologists' (ASA) classification of Physical Health.

Design outcomes

Primary

MeasureTime frameDescription
Changes from Baseline in intraabdominal pressure at timepoint immediate after- and 24 hours after abdominal skin closure.Baseline, immediate after- and 24 hours after abdominal skin closure: By an Unometer, attached to a standard catheter in the bladder, we measured the intravesical pressure as a surrogate marker for the IAP, at baseline, immediate after- and 24 hours after abdominal skin closure

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026